ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,717.00
-1.12%
S&P ASX All Technology
3,062.90
-0.63%
Brent Oil
83.675
0.14%
US Dollar vs AUD
1.52032
-0.01%
Bitcoin
61,614.76
0.70%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Oaktree Acquisition Corp II (OACB)

  7. Oaktree Acquisition Corp II (OACB) News

OACB

Oaktree Acquisition Corp... (OACB)

Oaktree Acquisition Corp II
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:OACB
DateTimeSourceHeadlineSymbolCompany
16/06/202201:36Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NYSE:OACBOaktree Acquisition Corp II
09/06/202221:10Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
09/06/202211:16Business WireAlvotech und Oaktree Acquisition Corp. II melden Zustimmung der Aktionäre zum UnternehmenszusammenschlussNYSE:OACBOaktree Acquisition Corp II
08/06/202219:54Business WireAlvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprisesNYSE:OACBOaktree Acquisition Corp II
08/06/202206:00Business WireAlvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business CombinationNYSE:OACBOaktree Acquisition Corp II
04/06/202207:29Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
04/06/202207:17Business WireOaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with AlvotechNYSE:OACBOaktree Acquisition Corp II
01/06/202207:19Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
24/05/202221:24Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
24/05/202221:00Business WireAlvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®NYSE:OACBOaktree Acquisition Corp II
17/05/202223:00Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
17/05/202205:08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:OACBOaktree Acquisition Corp II
16/05/202222:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
16/05/202222:00Business WireAlvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®NYSE:OACBOaktree Acquisition Corp II
11/05/202222:00Business WireAlvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business CombinationNYSE:OACBOaktree Acquisition Corp II
11/05/202208:34Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NYSE:OACBOaktree Acquisition Corp II
23/04/202206:31Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
21/04/202207:00Business WireAlvotech améliore son accès aux capitaux et optimise son processus d’entrée en bourse, prévue sur le NASDAQNYSE:OACBOaktree Acquisition Corp II
21/04/202202:45Business WireAlvotech verbessert Zugang zu Kapital und ebnet Weg für erwartete NASDAQ-NotierungNYSE:OACBOaktree Acquisition Corp II
20/04/202222:15Business WireAlvotech migliora l'accesso al capitale e semplifica il percorso verso la prevista quotazione in Borsa al NASDAQNYSE:OACBOaktree Acquisition Corp II
20/04/202208:00Business WireAlvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock ExchangeNYSE:OACBOaktree Acquisition Corp II
20/04/202207:26Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
19/04/202207:12Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
09/04/202200:01Business WireアルヴォテックとSTADA、アッヴィとの欧州特許紛争を解決してHumira®のクエン酸フリー高濃度バイオシミラーHUKYNDRA®（AVT02）発売への道を開くNYSE:OACBOaktree Acquisition Corp II
07/04/202211:15Business WireAlvotech et STADA ouvrent la voie au lancement de HUKYNDRA® (AVT02), un biosimilaire de l'Humira® haute concentration sans citrate, en réglant le litige de brevet européen qui les opposait à AbbVieNYSE:OACBOaktree Acquisition Corp II
07/04/202208:21Business WireAlvotech und STADA ebnen durch Beilegung des europäischen Patentstreits mit AbbVie den Weg für die Markteinführung von HUKYNDRA®(AVT02), einem zitratfreien, hochkonzentrierten Biosimilar zu Humira®NYSE:OACBOaktree Acquisition Corp II
06/04/202221:51Edgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
06/04/202221:00Business WireAlvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVieNYSE:OACBOaktree Acquisition Corp II
24/03/202207:20Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
14/03/202222:10Business Wireアルヴォテックがアッヴィとの米国特許・企業秘密紛争を解決し、Humira®向けにアルヴォテックが提案中の高濃度バイオシミラー（AVT02）の米国での権利を確保NYSE:OACBOaktree Acquisition Corp II
 Showing the most relevant articles for your search:NYSE:OACB

Your Recent History

FX
EURAUD
Euro vs AUD
ASX
WBC
Westpac Banking
FX
AUDCAD
AUD vs CAD
COIN
BTCUSD
Bitcoin
ASX
ANZ
Australia And New Zealan...
NYSE
DIS
Walt Disney
ASX
WDC
Westfield
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
RIO
Rio Tinto
ASX
NCM
Newcrest Mining
NYSE
MRK
Merck
ASX
WPL
Woodside Petroleum
NYSE
XOM
Exxon Mobil
ASX
ORG
Origin Energy
NASDAQ
TSLA
Tesla
ASX
SUN
Suncorp
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved